Publication Date: 2020-06-09
Practice Area: Civil Appeals | Civil Procedure
Industry: Federal Government | Pharmaceuticals
Court: U.S. Court of Appeals for the Second Circuit
Judge: Circuit Judge Dennis Jacobs
Attorneys: For plaintiff: For Plaintiff-Appellant United States of America ex rel. Don Hanks: Rob Hennig, Hennig Ruiz & Singh, P.C., Los Angeles, CA.
For Appellee United States of America: Bruce R. Ellisen, on the brief, Julie Ciamporcero Avetta, for Richard E. Zuckerman, Principal Deputy Assistant Attorney General, Department of Justice, Washington, DC, Richard P. Donaghue, United States Attorney for the Eastern District of New York, of counsel.
for defendant: For Defendants-Appellees Florida Cancer Specialists & Research Institute, LLC, Ayub, Sokol, Matzkowitz and Sennabaum, M.D.s, P.A. d/b/a New Hope Cancer Center, Coastal Oncology, P.L., J. Paonessa, M.D., P.A. (Gulfcoast Oncology Associates), and Pasco Hernando Oncology Associates, P.A.: Rachel Kramer, Michael P. Matthews, on the brief, Lawrence M. Krauss, Foley & Lardner LLP, Boston, MA.
For Defendant-Appellee U.S. Oncology Specialty, LP.: Samuel B. Goldstein, Joshua Hill, Jr., Lena H. Hughes, on the brief, Joseph R. Palmore, Morrison & Foerster LLP, Washington, DC.
For Defendants-Appellees Central Georgia Cancer Care, P.C., Georgia Cancer Specialists I, P.C., and Southeast Georgia Hematology Oncology Associates, P.C.: Jeremy P. Burnette, Akerman LLP, Atlanta, GA.
For Defendant-Appellee Northwest Georgia Oncology Centers, P.C.: Michael E. Paulhus, Jennifer S. Lewin, on the brief, James W. Boswell, III, King & Spalding LLP, Atlanta, GA.
Case Number: 18-3376
District Court Must Decide if Qui Tam Action Is Barred by FCA's Public Disclosure Bar